Assessment of Test Performance and Potential for Environmental Contamination Associated with a Point-of-Care Molecular Assay for Group A Streptococcus in an End User Setting
Author(s) -
Leslie J. Donato,
Nikki K. Myhre,
Martha A. Murray,
Margaret R. McDonah,
Jane F. Myers,
Julie Maxson,
Alicia M. Meek,
Mark J. Espy,
Joseph W. Furst,
Brad S. Karon,
Matthew J. Binnicker
Publication year - 2018
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.01629-18
Subject(s) - point of care , concordance , contamination , medicine , point of care testing , food and drug administration , streptococcus , medical physics , biology , environmental health , pathology , ecology , genetics , bacteria
Although U.S. Food and Drug Administration-approved and CLIA-waived point-of-care (POC) molecular systems are being implemented in routine clinical practice, instrument reliability, test performance in the hands of end users, and the potential for environmental contamination resulting from use of POC molecular systems have not been extensively evaluated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom